Sen. Elizabeth Warren (D-Mass.) condemned Demetrios Kouzoukas’ “overwhelming conflicts of interest” as a board member for a private insurance company.
The Massachusetts Democrat grew more agitated as the nominee to federal health insurance boards dodged her questions.
"I’m simply a daughter who cares about her parents. And I’m a citizen looking around at our irrational health care system and feeling helpless, enraged and scared."
Why Republican Presidential Contenders Are Mostly Silent About Biden’s Signature Prescription Drug Policy
Donald Trump is more vocal than his GOP rivals, but he failed to pass a bill reducing drug costs while in office.
It's the first step in a process that will mean lower prices in 2026 ― unless the drug industry and its allies find a way to block it.
The Biden administration plans to name the first 10 Medicare drugs subject to price negotiation, while pharmaceutical companies try to block the effort in court.
A lawsuit that PhRMA filed Wednesday is the latest fusillade against one of the president’s biggest domestic achievements.
Two big bills come due in early June, and they could be enough for Treasury Secretary Janet Yellen to set a hard deadline.
This year's budget would increase payroll taxes for higher-income Americans, while strengthening the program's new power to negotiate drug prices.
There are echoes of 'I'm rubber, you're glue' as the GOP desperately fends off attacks on its debt ceiling gambit.